• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    阿

    阿肯色医科大学

    University of Arkansas for Medical Sciences,University of Arkansas System
    院校EST. 1879
    3.2万论文总数
    100万引用总数

    The University of Arkansas for Medical Sciences (UAMS) is a public health sciences university in Little Rock, Arkansas. It is part of the University of Arkansas System and consists of six colleges, seven institutes, several research centers, a statewide network of community education centers, and the UAMS Medical Center.

    论文量&引用量时间轴

    机构学者

    排序
    Bart Barlogie
    Bart Barlogie
    Icahn School of Medicine at Mount Sinai
    论文:838引用:0H-index:0
    Rhee Frits van
    Rhee Frits van
    Myeloma Center/Division of Hematology Oncology/Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
    论文:535引用:0H-index:0
    Jawahar L. Mehta
    Jawahar L. Mehta
    Cardiology Clinic, University of Arkansas for Medical Sciences Medical Center;Department of Physiology and Cell Biology, College of Medicine, University of Arkansas for Medical Sciences
    论文:410引用:0H-index:0
    John D. Shaughnessy Jr
    John D. Shaughnessy Jr
    University of Arkansas for Medical Sciences
    论文:368引用:0H-index:0
    Guido Tricot
    Guido Tricot
    Department of Internal Medicine, Carver College of Medicine, University of Iowa
    论文:300引用:0H-index:0
    Elias Anaissie
    Elias Anaissie
    CTI Clinical Trial and Consulting Services
    论文:293引用:0H-index:0
    Eric R. Siegel
    Eric R. Siegel
    Department of Biostatistics, University of Arkansas for Medical Sciences
    论文:250引用:0H-index:0
    Gareth J Morgan
    Gareth J Morgan
    Univ Arkansas Med Sci, Myeloma Inst, Little Rock, AR 72205 USA
    论文:191引用:0H-index:0
    Maurizio Zangari
    Maurizio Zangari
    University of Arkansas for Medical Sciences
    论文:178引用:0H-index:0

    论文(10000)

    年份
    起
    –
    止
    排序
    1Extracorporeal Membrane Oxygenation, Acute Kidney Injury, Fluid Balance, and Continuous Renal Replacement Therapy: Acute Disease Quality Initiative (ADQI) and Extracorporeal Life Support Organization (ELSO) Joint Consensus Conference
    Katja M. Gist, David T. Selewski,Kianoush B. Kashani,Ayse Akcan-Arikan, Gail Annich, Marta V. Antonini,David Askenazi,Linda Awdishu,Brian C. Bridges, Michael J. Connor,Lui G. Forni,Dana Y. Fuhrman,

    Extracorporeal membrane oxygenation (ECMO) is increasingly being utilized for life-threatening cardiac and/or respiratory failure refractory to conventional treatment. Acute kidney injury (AKI) and fluid balance disorders commonly occur both before and during ECMO, with approximately half of cases receiving treatment with continuous renal replacement therapy (CRRT). Acute kidney injury, fluid balance disorders, and CRRT influence both short- and long-term outcomes in this population. The 36th Acute Disease Quality Initiative (ADQI) meeting was held in June 2025 to develop multidisciplinary international expert recommendations for AKI, fluid balance, and CRRT during ECMO across the age spectrum. This work encompassed five working groups: 1) epidemiology, risk factors, and outcomes of AKI and CRRT, 2) fluid management and outcomes, 3) indications for CRRT and fluid removal during ECMO, 4) best practices for performing CRRT during ECMO, and 5) biomarkers, extracorporeal blood purification, and drug pharmacokinetics and pharmacodynamics. As part of this work, knowledge gaps and research priorities were identified.

    2026Intensive Care Medicine(2026)引用:85
    引用
    AI阅读
    加入学术空间
    2Fluid Accumulation and Outcomes in Children Receiving Continuous Kidney Replacement Therapy: an Appraisal of the WE-ROCK Registry
    David T. Selewski,Katja M. Gist,Akash Deep, Lama Elbahlawan,Dana Y. Fuhrman,Ben Gelbart, Stephen M. Gorga, Kenneth E. Mah,Nicholas J. Ollberding, Stephanie Reynaud, Jangdong Seo,Danielle E. Soranno,

    The prospective pediatric Continuous Renal Replacement Therapy (ppCRRT) registry identified the degree of fluid accumulation (FA) at continuous kidney replacement therapy (CKRT) initiation as a predictor of adverse outcomes in children. These predate major advancements in CKRT technology and fluid stewardship. We aimed to describe the epidemiology of FA at CKRT initiation and associated outcomes in a contemporary paediatric cohort. Secondary analysis of Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK), a retrospective, multicenter study (35 centers, 9 countries) of patients ≤ 25 years treated with CKRT from 2015 to 2021. Primary Outcome: survival to ICU discharge. Secondary outcomes: ventilator-free and ICU-free days. A total of 1027 patients were included in this analysis. Survival to ICU discharge was 64.5

    2026Pediatric Nephrology(2026)引用:32
    引用
    AI阅读
    加入学术空间
    3Developing a Core Outcome Set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a Modified Delphi Study.
    David S. Hersh,Anthony L. Asher, Mohamad Bydon, Maliya Delawan,Ian F. Pollack, Jason S. Hauptman, Eric M. Thompson,Michael C. Dewan,S. Hassan. A. Akbari, Karl Balsara, Randaline R. Barnett, Marian M. Bercu,

    Prospective, multi-institutional surgical data collection in pediatric neuro-oncology remains limited despite substantial variation in operative and perioperative management across institutions. To address this, we are developing the NeuroPoint Alliance (NPA) Quality Outcomes Database (QOD) Pediatric Tumor Surgery Registry. Here, we used a modified Delphi process to define a core outcome set for the registry. A modified Delphi study was conducted among pediatric neurosurgeons serving as site principal investigators for the proposed registry. Candidate data elements were rated on a 9-point Likert scale. Consensus for inclusion was predefined as ≥70

    2026Journal of Neuro-Oncology(2026)引用:28
    引用
    AI阅读
    加入学术空间
    4Are Psychiatry Faculty Prepared to Guide AI Use? A National Survey.
    Amelia Elizabeth Mercado, Lauren Ferguson, Jonathan Chastain, Julie Williams, Ramzi W. Nahhas, Samidha Tripathi, Larrilyn Grant

    OBJECTIVE:To assess psychiatry faculty knowledge, use, and perceptions of artificial intelligence (AI) in undergraduate medical education (UME) and graduate medical education (GME), and examine awareness of institutional AI policies. METHODS:A national survey was distributed to psychiatry clerkship directors and residency program directors at 105 allopathic and osteopathic medical schools and 219 psychiatry residency programs across the USA from November 2024 to February 2025. The survey assessed AI use patterns, attitudes, perceptions, and awareness of institutional policies. Data were analyzed using descriptive statistics and Fisher's exact test for group comparisons. RESULTS:Responses were obtained from 31 UME faculty (29.5% response rate) and 46 GME faculty (21% response rate). All UME faculty and 74% of GME faculty believed students use AI. However, 36% of UME and 57% of GME faculty were unaware of institutional student AI policies. Knowledge of faculty AI policies was even more limited (38.7% UME, 63% GME uncertain). Only 35.5% of UME and 27.9% of GME faculty reported current AI use, primarily for research support, literature review, and content development. Overall, 50% of UME and 54.1% of GME respondents perceived AI in medical education as beneficial. CONCLUSIONS:Despite widespread belief that students use AI, psychiatry faculty demonstrate limited awareness of institutional policies and minimal integration of AI literacy in curricula. These findings highlight the urgent need for faculty development programs, clear institutional policies, and structured AI curricula to bridge the gap between rapid AI adoption by learners and educational infrastructure.

    2026Academic Psychiatry(2026)引用:23
    引用
    AI阅读
    加入学术空间
    5Region- and Compartment-Specific Elevation of Bone Mass in Mice Following Tsc1 Deletion in 8-Kb Dmp1-Cre-Expressing Cells
    Iya Ghassib, Anusha Inti, Nushaba Hossain, Thomas Kim, Danielle Moon, Lu Han, Rawan Mohsen,Honghao Zhang, Nicholas Auyeung,Yuji Mishina,Daniela Mendonça,Darnell Kaigler,

    Tuberous sclerosis complex 1 (TSC1) is a negative regulator of mTORC1 signaling, a key pathway in skeletal homeostasis, but its region- and compartment-specific effects on bone remain unclear. Here, we examined the skeletal impact of Tsc1 deletion using the 8-kb Dmp1-Cre line, which targets mature osteoblasts and osteocytes. Cre activity in Ai14 reporter mice showed comparable recombination in craniofacial, appendicular, and axial bones. Conditional Tsc1 deletion resulted in greater bone mass at multiple sites, but with marked regional and compartmental variations. In the craniofacial skeleton, the frontal bone showed the most robust elevation in thickness and volume, the parietal bone displayed intermediate elevation, and the mandible exhibited the smallest elevation but reduced bone volume fraction and tissue mineral density, consistent with greater porosity. In femurs, both trabecular and cortical bone mass was augmented. Histomorphometric analysis of femoral trabecular bone revealed increased osteoblast number and surface together with reduced osteoclast parameters. In vertebrae, Tsc1 deletion produced modest trabecular bone accrual but > 100

    2026Calcified Tissue International(2026)引用:21
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 10000 篇论文

    合作机构(100)

    华盛顿大学合作论文 662
    Arkansas Children''s Hospital合作论文 659
    阿肯色大学合作论文 604
    埃默里大学合作论文 476
    杜克大学合作论文 432
    佛罗里达大学合作论文 408
    密歇根大学合作论文 395
    贝勒医学院合作论文 376
    北卡罗来纳大学系统合作论文 374
    犹他大学合作论文 371

    机构统计